Nodule in pathology
pulmonary nodule CT scan pathology

This diagnostic figure consists of two axial CT scan sections of the chest demonstrating pulmonary and pleural pathology. (a) A non-contrast axial CT in lung window settings reveals a discrete, approximately 1.5 cm nonspecific pulmonary nodule in the right upper lobe, indicated by a white arrow. The nodule is well-circumscribed and located within the peripheral lung parenchyma. (b) A contrast-enhanced axial CT scan performed in the prone position at the level of the 9th thoracic vertebra. It displays bilateral latero-spinal subpleural thickening (indicated by arrows) and a localized right-sided pleural effusion (indicated by a white arrowhead). The image demonstrates typical radiological findings associated with systemic inflammatory or granulomatous diseases such as Granulomatosis with Polyangiitis (GPA). These diagnostic images serve as an educational example of how multisystemic conditions present with varied intrathoracic manifestations, including parenchymal nodules and pleural involvement, requiring contrast-enhanced imaging for better soft tissue characterization.

Two axial CT scan slices of the chest in lung window demonstrate multifocal pulmonary pathology. Panel (a) shows a 1.7 cm cavitary nodule (indicated by an arrow) located peripherally in the left lower lobe. The nodule features a relatively thick wall and a central area of lucency, suggesting necrosis or cavitation. Panel (b) reveals a larger 3 cm mass-like infiltrate or consolidation (indicated by an arrow) in the right lower lobe, also positioned peripherally near the pleural surface. The infiltrate displays irregular borders and increased density compared to normal lung parenchyma. These findings are characteristic of infectious processes such as disseminated mycobacterial infection (e.g., Mycobacterium fortuitum) or nocardiosis, which often manifest with peripheral nodules, cavitation, and multifocal pneumonia in immunocompromised or critically ill patients. The image is suitable for medical education in pulmonology, radiology, and infectious diseases.

Diagnostic axial CT scan of the chest presented in lung window settings, demonstrating a localized area of pathology within the pulmonary parenchyma. The primary finding is a solitary, pure ground-glass nodule (GGN) located in the peripheral region of the left lung. This nodule is characterized by a hazy increase in lung density that does not obscure the underlying bronchial and vascular structures, consistent with adenocarcinoma in situ (AIS). The nodule exhibits a rounded morphology with ill-defined borders that blend into the surrounding normal lung tissue. There are no associated signs of solid components, pleural retraction, or spiculated margins. The background lung parenchyma appears otherwise clear with normal vascular markings. This image serves as a clinical example of early-stage lung adenocarcinoma screening and the radiographic features used to differentiate non-solid nodules from solid pulmonary masses.

An axial-view non-contrast chest computerized tomography (CT) scan illustrating thoracic anatomy and pulmonary pathology. The image displays a cross-section of the thoracic cavity including the lungs, mediastinum, heart, and musculoskeletal framework (vertebral body, ribs, and scapulae). A white arrow points to a solitary, small pulmonary nodule with ground-glass opacity characteristics located in the anterior segment of the right upper lobe. The nodule is situated within the peripheral lung parenchyma, in relative proximity to the anterior chest wall and the fourth rib. The imaging demonstrates varying radiodensities: low-density (black) air-filled lung tissue, intermediate-density (grey) soft tissues of the heart and thoracic wall musculature, and high-density (white) cortical bone. This diagnostic image is used in medical education to teach anatomical localization of lung lesions and the visual identification of early-stage pulmonary nodules during radiological screening or pre-operative planning.
| Type | CT Appearance | Significance |
|---|---|---|
| Solid | Homogeneous soft-tissue attenuation; obscures underlying vessels | Most common; variable malignant risk |
| Non-solid (Ground Glass) | Hazy increased density; does NOT obscure vessels/bronchi | Lower risk but associated with adenocarcinoma spectrum; volume doubling time ~813 days |
| Part-solid | Mixed: non-solid region + solid component | Highest malignant risk per unit size; volume doubling time ~457 days |
| Margin | Likelihood of Malignancy |
|---|---|
| Smooth/well circumscribed | More likely benign |
| Lobulated | More likely malignant (LR ~11 vs smooth) |
| Spiculated ("corona radiata") | Strongly predictive of malignancy (LR ~5.5-7) |
| Pleural retraction | Associated with malignancy (LR ~1.9) |
| Perifissural / lentiform | Usually an intrapulmonary lymph node - benign |
| Pattern | Significance |
|---|---|
| Central / diffuse | Benign (post-infectious granuloma) |
| Laminar / concentric | Benign (classic for histoplasmosis) |
| Popcorn + internal fat | Highly specific for hamartoma |
| Punctate or eccentric | Indeterminate - seen in 6-14% of malignant nodules |



Stromal
stromal tumor histology GIST gastrointestinal

This histology image depicts a gastrointestinal stromal tumor (GIST) in a hematoxylin and eosin stained tissue section. The slide shows background myxoid matrix with focal decreased cellularity, a feature more common in epithelioid GISTs than spindle cell GISTs. Tumor cells are arranged in clusters within a loose, mucoid stroma; epithelioid-appearing cells with round to polygonal nuclei and eosinophilic cytoplasm predominate in the myxoid zones, while denser cellular areas display spindle-shaped cells. The intercellular network includes a delicate capillary network, and mitotic figures are variable, often scarce in myxoid regions but may be present in denser tumor nests. Such myxoid change can complicate histologic interpretation and broaden the differential to other myxoid mesenchymal neoplasms (myxoid leiomyosarcoma, schwannoma, liposarcoma); confirmation with KIT (CD117) and DOG1 immunostains and KIT/PDGFRA mutational analysis is recommended. Clinically, recognizing this histologic variant supports tumor localization within the GI tract, influences risk stratification, and informs targeted therapy decisions (imatinib). The image emphasizes the spectrum of GIST architecture, including myxoid stroma, variable cellularity, epithelioid morphology, and the necessity for ancillary testing to establish a definitive diagnosis and guide management. These features have implications for prognosis and response to therapy. Ancillary testing, including immunohistochemistry and mutational profiling, is essential.

Histology image acquired by bright-field microscopy of a gastrointestinal stromal tumor (GIST), epithelioid variant, in a high-power field after hematoxylin and eosin staining. The tumor shows high cellularity with sheets and nests of round to polygonal epithelioid cells, abundant eosinophilic to clear cytoplasm, and conspicuous nucleoli. Nuclear crowding and marked pleomorphism are evident, with occasional mitotic figures noted at this magnification. The cells are separated by a delicate to moderate amount of hyalinized stroma and exhibit a relatively uniform, cohesive architecture despite cellular pleomorphism; there is minimal necrosis and no evident keratinization. This epithelioid morphology can closely resemble epithelioid carcinomas or melanoma, contributing to a broad differential diagnosis. In practice, immunohistochemical profiling (e.g., CD117/c-KIT, DOG1 positivity; cytokeratins and melanocytic markers typically negative) is essential to confirm GIST and exclude carcinoma or melanoma. Clinically, epithelioid GISTs may present in the stomach or small intestine and can be associated with activating KIT or PDGFRA mutations; prognosis depends on tumor size, mitotic rate, and location, impacting management with surgical resection and targeted therapy (imatinib). This image illustrates the histopathologic challenge of distinguishing epithelioid GIST from metastatic melanoma or epithelial malignancies on routine H&E, underscoring the need for ancillary testing in diagnostic workflows today.

This is a high-magnification histopathology image of a gastrointestinal stromal tumor (GIST) showing a spindle cell-dominant morphology. Tissue is examined by light microscopy after Hematoxylin and Eosin staining, at ×400 magnification, highlighting elongated, fusiform cells arranged in intersecting fascicles with ovoid to elongated nuclei and eosinophilic cytoplasm. The stroma appears fibrous to lightly myxoid, with preserved cellular detail and minimal necrosis in this field. The spindle cell population is characteristic of many GISTs and supports a mesenchymal neoplasm of the gastrointestinal tract. In clinical practice, GISTs commonly harbor activating mutations in the c-KIT (CD117) gene in about 80% of cases or in PDGFRA (~8%), leading to constitutive tyrosine kinase signaling. Immunohistochemical CD117 positivity is a key diagnostic surrogate; DOG1 is frequently positive and may aid in challenging cases. Accurate molecular testing for c-KIT and PDGFRA mutations informs prognosis and eligibility for targeted therapy with tyrosine kinase inhibitors such as imatinib. This image serves as a reference for recognizing spindle cell GIST histology, differentiating it from smooth muscle or neural tumors, and illustrating how morphology guides ancillary testing, mutation profiling, and therapeutic decision-making in gastroenterology oncology and surgical pathology. This education-oriented caption emphasizes diagnostic workflow and targeted therapy implications for practice.
"All tumors, benign and malignant, have two basic components: (1) parenchyma, made up of transformed or neoplastic cells; and (2) stroma, the supporting host-derived, nonneoplastic connective tissue, inflammatory cells, and blood vessels."
"Within most organs, connective tissue proper forms the supportive stroma, which supports the organ's unique functional components or parenchyma."
| Component | Role |
|---|---|
| Fibroblasts / fibrocytes | Synthesize collagen, elastin, and ground substance |
| Extracellular matrix (ECM) | Protein fibers (collagen, elastin) + ground substance (GAGs, proteoglycans) |
| Blood vessels | Deliver oxygen and nutrients to parenchymal cells |
| Inflammatory / immune cells | Macrophages, lymphocytes, mast cells - homeostasis and defense |
| Smooth muscle / myofibroblasts | Structural support, wound contraction |
| Stroma Type | Tumors Arising |
|---|---|
| Intralobular stroma | Fibroadenoma (benign), Phyllodes tumor (variable) |
| Interlobular stroma | Lipoma, angiosarcoma, myofibroblastoma |

| Type | Features |
|---|---|
| Benign stromal nodule | Well-circumscribed; does not invade |
| Low-grade endometrial stromal sarcoma | Infiltrating; JAZF1-SUZ12 fusion gene (chromosomal translocation disrupts polycomb complex); 5-yr survival: ~90% (stage I/II), ~50% (stage III/IV) |
| High-grade endometrial stromal sarcoma | YWHAE-NUTM2A/B or ZC3H7B-BCOR fusions; more aggressive; distant metastases may appear decades later |

| Risk Level | Size | Mitoses/50 HPF |
|---|---|---|
| Very low | < 2 cm | < 5 |
| Low | 2-5 cm | < 5 |
| Intermediate | < 5 cm / 5-10 cm | 6-10 / < 5 |
| High | > 5 cm OR > 10 cm | > 5 / Any |
| Feature | Stromal (Mesenchymal) Tumors | Epithelial / Parenchymal Tumors |
|---|---|---|
| Cell of origin | Fibroblasts, smooth muscle, endothelium, ICC | Epithelial cells |
| Naming (benign) | -oma (fibroma, lipoma, leiomyoma) | Adenoma, papilloma |
| Naming (malignant) | Sarcoma | Carcinoma |
| Spread | Hematogenous (blood-borne) | Lymphatic (then blood) |
| Examples | GIST, fibroadenoma, phyllodes, leiomyoma, angiosarcoma | Breast carcinoma, colon adenocarcinoma |